• S Tag Peptide: Technical Guide for Protein Fusion Workflows

  2026-07-09

  S Tag Peptide (SKU A6007) addresses challenges in recombinant protein workflows by improving solubility and enabling robust detection and purification through anti-S-Tag antibody systems. It is optimal for applications in molecular biology where ethanol solubility is not required and compatible detection reagents are validated. Avoid use in workflows demanding long-term peptide solution storage or ethanol-based systems.

• MG-132 (A2585): Reliable Proteasome Inhibition for Cell Assa

  2026-07-09

  This article provides scenario-driven, evidence-based guidance for using MG-132 (SKU A2585) in cell viability and apoptosis workflows. It addresses common laboratory challenges such as assay reproducibility, workflow optimization, and vendor reliability, highlighting how MG-132 from APExBIO enables robust and interpretable data in biomedical research.

• Biotin-tyramide: Mechanism, Benchmarks, and TSA Applications

  2026-07-08

  Biotin-tyramide is a validated biotinylation reagent for tyramide signal amplification (TSA), enabling high-resolution detection in IHC and ISH. Its specificity, solubility, and enzyme-mediated deposition mechanism are critical for robust signal enhancement. APExBIO’s A8011 product is backed by quantitative purity and performance data.

• Angiotensin Peptides Potentiate SARS-CoV-2 Spike–Host Recept

  2026-07-08

  The referenced study uncovers that specific angiotensin peptide fragments, including Angiotensin 1/2 (2-7), enhance SARS-CoV-2 spike protein binding to its cellular receptors, particularly AXL. These findings provide novel insight into the intersection between renin-angiotensin signaling and viral entry mechanisms, suggesting new avenues for both cardiovascular and infectious disease research.

• Stiripentol as an LDH Inhibitor: Protocols for Lactate Modul

  2026-07-07

  Stiripentol offers researchers precision control of lactate metabolism for dissecting neuroepileptic and immunometabolic pathways. This article unpacks how to optimize Stiripentol-based workflows for epilepsy and tumor microenvironment studies, highlighting troubleshooting tips and evidence-based assay enhancements.

• Losartan in Translational Research: Mechanisms, Models, and

  2026-07-07

  Explore how Losartan, a selective angiotensin II receptor antagonist, is shaping translational research through mechanistic insight, robust experimental validation, and cross-domain opportunities—now including tumor microenvironment modulation to enhance immunotherapy.

• Bradykinin (BA5201): Technical Guidance for Vasodilator Stud

  2026-07-06

  Bradykinin (BA5201) is designed for researchers investigating endothelium-dependent vasodilation, vascular permeability, and related pain or inflammation mechanisms in controlled laboratory settings. It is best utilized where precise modulation of vascular and nonvascular smooth muscle responses is required; it is not intended for diagnostic, clinical, or long-term in vivo applications.

• Guanabenz Acetate and the Modulation of Innate Immunity Path

  2026-07-06

  Explore how Guanabenz Acetate, a potent α2-adrenergic receptor agonist, is advancing our understanding of innate immunity modulation beyond classical receptor signaling. This article unpacks novel mechanistic insights and practical assay considerations, setting it apart from conventional narratives.

• Antipyrine in Blood-Brain Barrier Models: Precision Tools fo

  2026-07-05

  Explore how Antipyrine (1,5-dimethyl-2-phenylpyrazol-3-one) is transforming in vitro blood-brain barrier modeling and CNS drug discovery. This comprehensive analysis reveals its unique value in high-throughput permeability assays and experimental design.

• Pepstatin A: Aspartic Protease Inhibitor for Advanced Assays

  2026-07-04

  Pepstatin A empowers high-fidelity studies of viral protein processing and osteoclast differentiation, thanks to its ultra-pure, potent inhibition of aspartic proteases. This article offers actionable workflows, troubleshooting strategies, and novel insights grounded in both peer-reviewed research and APExBIO’s trusted reagent quality.

• Microfluidized Dextran Microgels for Oral Colon Cancer Thera

  2026-07-03

  This study introduces a dual-targeted, microfluidized dextran microgel system for oral delivery of cisplatin and SPION-loaded lipid nanoparticles, specifically designed for local colon cancer treatment. The platform demonstrates enhanced colon retention, targeted cellular uptake, and synergistic chemo/magnetothermal effects, offering significant improvements in therapeutic efficacy and reduced systemic toxicity.

• Pepstatin A: Precision Aspartic Protease Inhibitor Workflows

  2026-07-03

  Pepstatin A enables targeted inhibition of aspartic proteases in diverse experimental systems, from viral protein processing to osteoclast differentiation studies. This article delivers advanced, data-driven protocols, troubleshooting strategies, and translational insights to maximize reliability and specificity in protease inhibition assays.

• Cediranib (AZD2171): Advanced Applications in Cancer Researc

  2026-07-02

  Cediranib (AZD2171) empowers researchers to dissect angiogenesis and tumor signaling through potent, selective VEGFR inhibition. This article details experimental strategies, troubleshooting, and evidence-backed workflows that leverage Cediranib’s unique properties for reproducible, high-impact cancer research.

• (S)-Mephenytoin: CYP2C19 Substrate Workflows for Human Organ

  2026-07-02

  (S)-Mephenytoin sets the benchmark for CYP2C19 substrate-based drug metabolism studies, especially in advanced hiPSC-derived intestinal organoid systems. This guide unpacks its protocol nuances, comparative advantages, and troubleshooting strategies—empowering translational research in pharmacokinetics and precision medicine.

• 2,5-di-tert-butylbenzene-1,4-diol (BHQ) in Calcium Signaling

  2026-07-01

  2,5-di-tert-butylbenzene-1,4-diol (BHQ) is redefining calcium homeostasis disruption and hematopoietic stem cell mobilization through selective SERCA inhibition. Its validated performance in protocol optimization and translational studies positions APExBIO’s BHQ as a pivotal tool for advanced stem cell and vascular workflows.

16273 records 1/1085 page Next 12345 下5页 Last page